Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | PLK1 | P53350 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3971183 | 0.85 | ALDH1A1 (0.57) | ALDH1A1PLK1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL6687329 | 0.85 | ALDH1A1 (0.57) | ALDH1A1PLK1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL13543227 | 0.83 | PLK1 (0.56) | ALDH1A1PLK1TDP1NPC1RAB9A | |
| SCHEMBL3128806 | 0.83 | ALDH1A1 (0.55) | ALDH1A1PLK1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL10031827 | 0.83 | PGR (0.47) | ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL27627345 | 0.83 | ALDH1A1 (0.55) | ALDH1A1PLK1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL4457411 | 0.83 | ALDH1A1 (0.55) | ALDH1A1PLK1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL8242799 | 0.83 | EPHX2 (0.50) | ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL10458493 | 0.81 | CYP1A2 (0.48) | ALDH1A1PLK1SMN1; SMN2HPGDRXRA | |
| SCHEMBL13389977 | 0.81 | THRA (0.59) | ALDH1A1PLK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3665163-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | Symrise AG (DE) | 2020-06-17 | — | — | EP | claimed |
| CN-117090046-A | Composition for reducing malodor and use thereof | 阿吉莱克斯香料和香水公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023196616-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2023-10-12 | — | — | WO | disclosed |
| US-11731967-B2 | Inhibitors of TRIM33 and methods of use | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-08-22 | — | — | US | disclosed |
| CN-113423700-A | Amber flavor agent | 弗门尼舍有限公司 | 2021-09-21 | — | — | CN | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| EP-2188364-B2 | FABRIC TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2020-12-30 | — | — | EP | disclosed |
| EP-3668850-A1 | AMBER ODORANT | Firmenich SA (CH) | 2020-06-24 | — | — | EP | disclosed |
| EP-3665163-A1 | USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT | Symrise AG (DE) | 2020-06-17 | — | — | EP | disclosed |
| EP-3166586-B1 | ANHYDROUS OIL BASED ON DELIVERY PARTICLES CONTAINING A BENEFIT AGENT | OREAL (FR) | 2020-04-15 | — | — | EP | disclosed |
| US-20080057005-A1 | HYDROGELS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2008-03-06 | — | — | US | disclosed |
| US-20070122738-A1 | IMAGE FORMING MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122738-A1 | IMAGE FORMING MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1765139-A1 | ROLLER FOR PROVIDING BENEFITS TO FABRIC | The Procter and Gamble Company (US) | 2007-03-28 | — | — | EP | disclosed |
| US-7160667-B2 | Novolak phenolic resin, quaternary heterocyclic amine, and -onium or ammonium photo-thermal converting agents; positive planographic printing plate precursor; storage stability | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-09 | — | — | US | disclosed |
| US-7160667-B2 | Novolak phenolic resin, quaternary heterocyclic amine, and -onium or ammonium photo-thermal converting agents; positive planographic printing plate precursor; storage stability | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-09 | — | — | US | disclosed |
| WO-2006010087-A1 | ROLLER FOR PROVIDING BENEFITS TO FABRIC | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-26 | — | — | WO | disclosed |
| WO-1999016735-A1 | METHOD FOR MAKING ACETAL COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-08 | — | — | WO | disclosed |
| EP-0639558-B1 | Process for preparation of 1-acyl-2-substituted-hydrazines | NIPPON KAYAKU KK (JP) | 1996-10-23 | — | — | EP | disclosed |
| EP-0639558-A1 | Process for preparation of 1-acyl-2-substituted-hydrazines | Nippon Kayaku Kabushiki Kaisha (JP) | 1995-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731967-B2 | Inhibitors of TRIM33 and methods of use | TRIM33, TRIM28, TRIM4 | ALDH1A1 3246/4885PLK1 1011/4885SMN1; SMN2 639/4885 |
| US-20080057005-A1 | HYDROGELS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | GMPS, CGAS, PDE2A | ALDH1A1 974/4885PLK1 3360/4885SMN1; SMN2 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.